3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Carcinoma, Renal Cell
40
Kidney Neoplasms
30
Melanoma
25
Prostatic Neoplasms
24
Breast Neoplasms
18
Wilms Tumor
16
Neoplasm Metastasis
16
Ovarian Neoplasms
14
Carcinoma, Non-Small-Cell Lung
12
Testicular Neoplasms
11
Multiple Myeloma
11
Uterine Cervical Neoplasms
10
Sarcoma
9
Pancreatic Neoplasms
9
Neuroblastoma
9
Testicular Germ Cell Tumor
8
Lymphoma, Follicular
8
Lymphoma
8
Lung Neoplasms
8
Hodgkin Disease
8
Carcinoma, Hepatocellular
8
Triple Negative Breast Neoplasms
7
Neoplasms, Plasma Cell
7
Neoplasms
7
Lymphoma, Non-Hodgkin
7
Lymphoma, Mantle-Cell
7
Lymphoma, Large-Cell, Immunoblastic
7
Lymphoma, Large B-Cell, Diffuse
7
Leukemia, Myeloid, Acute
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Interventions
Specimen Handling
3
Nivolumab
2
Magnetic Resonance Spectroscopy
2
sargramostim
1
rucaparib
1
pembrolizumab
1
belinostat
1
X-Rays
1
Tissue Banks
1
Ipilimumab
1
Immunoglobulin G
1
Fluorouracil
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
Cyclophosphamide
×
Genitourinary
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled